These results, together with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 aid the notion of focusing on ACKR3 as a novel technique to modulate the opioid method, which could open up new therapeutic avenues for opioid-similar Diseases. Furthermore, the conolidine molecule https://edwardu368rqg5.blogofchange.com/profile